相关实验视频
Updated: May 5, 2026
09:54
A Model to Simulate Clinically Relevant Hypoxia in Humans
Published on: December 22, 2016
8.8K
甲基化物和急性中枢神经系统氧毒性风险:动物模型和人类多样性的观察数据
Ivan Gur1,2, Yehuda Arieli3, Yinnon Matsliah4
1Rambam Medical Center, Haifa, Israel.
Diving and hyperbaric medicine
|September 17, 2024
概括
用于ADHD的甲基酸盐不会增加中央神经系统氧毒性 (COT) 风险. 在小鼠中,甲基酸盐延长了COT发病的时间,表明了潜在的保护作用.
科学领域:
- 高压医学的高压医学.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 中枢神经系统氧毒性 (COT) 是使用纯氧呼吸器的潜水员面临的风险.
- 甲基胺,一种常见的ADHD药物,对COT的影响以前没有研究过.
- 了解潜在的药物相互作用对于潜水员安全至关重要.
研究的目的:
- 调查甲基酸盐使用与在水族中发展COT的风险之间的联系.
- 评估甲基胺对动物模型中COT发作的延迟的影响.
主要方法:
- 对纯氧-再呼吸潜水员记录 (1975-2022) 的回顾性分析,以确定COT病例并评估甲基胺的使用情况.
- 匹配的病例控制研究,将潜水员与COT与类似的对照进行比较.
- 在小鼠实验中进行了一项涉及口服甲基尼达的实验研究,随后暴露在高压氧气中,直到发作开始.
主要成果:
- 没有发现甲基酸盐处方与人类潜水员中COT风险增加之间有统计学意义的关联 (OR 0.72).
- 在小鼠中,增加甲基酸的剂量与显著延长COT发病的延迟时间有关.
- 在小鼠中,COT的平均延迟时间随着甲基胺剂量的增加而增加,从877s (0 mg/kg) 增加到1500s (5 mg/kg).
结论:
- 人类观察数据表明,甲基化物不会在水族中增加COT风险.
- 在小鼠中,甲基胺暴露似乎延长了中枢神经系统氧气毒性的延迟时间.
- 这些发现表明,甲基化物可能具有对COT的保护作用.
相关概念视频
01:36Types of Toxins
3.7K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.7K
01:24Drug Toxicity: Risk factors
229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
01:23Toxicity Testing in Animals
204
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
204